Interview with Decibel Therapeutics' New CEO
- Thread starter beeeep
- Start date
Member
Decibel Therapeutics Announces Investment from GV to Expand Capabilities for Biological Target Identification in Hearing Loss and Tinnitus
http://www.businesswire.com/news/ho...s-Announces-Investment-GV-Expand-Capabilities
http://www.businesswire.com/news/ho...s-Announces-Investment-GV-Expand-Capabilities
we'll have to wait one year before results...while more nice news will come.. it seems like a revolution.
we are living things that were almost science ficcion 5 years ago...im sure that this is the first.
we are living things that were almost science ficcion 5 years ago...im sure that this is the first.
Last data collection is planned for this September. So well probably know in less than a year...
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372587
In the link says that the duration of the study will be 10 months
In the link says that the duration of the study will be 10 months
Fabrikat
Member
- May 1, 2017
- 416
- Tinnitus Since
- 1973
- Cause of Tinnitus
- Otosclerosis then volume then viral infection
Frequency have also opened an office in Melbourne. Seperate to the hospital where the testing is being done and to Melbourne University, which is also involved. It's all very interesting.
Fabrikat
Member
- May 1, 2017
- 416
- Tinnitus Since
- 1973
- Cause of Tinnitus
- Otosclerosis then volume then viral infection
No one knows what the selection criteria will be for future trials until they announce them. More likely to be conducted in the US however. The Frequency threads will have more information as it becomes known. You can count on that!
Just the fact that they recently received financial investment from GV is an encouraging sign. They wouldn't invest in a company and it's ideas unless they believed that they were credible and showed promise for the future.:
https://decibeltx.com/wp-content/uploads/2017/07/GV-Press-Release_7.6.17_FINAL.pdf
https://www.gv.com/team/
https://decibeltx.com/wp-content/uploads/2017/07/GV-Press-Release_7.6.17_FINAL.pdf
https://www.gv.com/team/
- Aug 21, 2014
- 5,049
- Tinnitus Since
- 1999
- Cause of Tinnitus
- karma
I agree, but do keep in mind that the general VC model is to bet on stuff expecting 90% of it to fail, 9% of it to maybe make your money back, and 1% of it to do so well that it pays for the 90% that failed and then some. So, looking at it from that point of view, Alphabet thinks its 1 in 100 or better than Decibel will make a lot of money.
e: to be clear, I do think there's been enough real progress in this area to expect that at some point within the next several decades* there will be hearing regenerative therapies that work for some people. But, whether any of the exact drugs and approaches that are in the pipeline right now will pan out, is anyone's guess.
* this assumes that global instability and climate change do not accelerate to the point where scientific progress halts; this may not be a safe assumption.
From this interview, I suggested that they consider ototoxicity from the point of view of "prevention", prevention, in the treatment of various ototoxic drugs (aminoglycosides, cisplatin, etc.), and not restoration (regeneration) of hearing loss after the already existing ototoxic damage. If so, then it grieves. I wrote to many companies related to the study of tinnitus and hearing loss, in particular, I was already interested in hearing loss due to ototoxic drugs. But all companies are engaged only in search, preventing ototoxicity, but no more. I also wrote a letter "Decibel terapeutucs" and they answered me very closed. They were advised to subscribe to their twitter. Let's all subscribe, so that they see that their work is necessary for us, and thus we will motivate them! ps. so what about real regeneration while you can talk only in the case of companies "Frequency terapeuticus", or are there any other companies in the world?
Here is the answer to my letter -
"Thank you for your email. Decibel is an early stage company developing drugs for a wide variety of hearing losses through many curative mechanisms. For the purposes of confidentiality, I cannot be more specific about our indications, targets, or timelines. I invite you to keep up with the latest at Decibel byfollowing us on Twitter (@DecibelTx)."
Here is the answer to my letter -
"Thank you for your email. Decibel is an early stage company developing drugs for a wide variety of hearing losses through many curative mechanisms. For the purposes of confidentiality, I cannot be more specific about our indications, targets, or timelines. I invite you to keep up with the latest at Decibel byfollowing us on Twitter (@DecibelTx)."
I suspect we won't hear much from any of these companies because they are all trying to be the first to market. We might get an update after a trial has been complete. Decibel hasn't even started a trial so it would appear they are behind.
Excuse me, what kind of legal proceedings are we talking about? There are no more such large companies working on regeneration in the world, except frequency and decibel terapeutics? Do you know anything about the treatment of ototoxicity from these companies?
I am following them now on Linkedin. Surprisingly Frequency therapeutics only has 317 followers. Decibel therapeutics has 1207 followers. Also not a lot.
Generally if you are conducting a clinical trial, you don't talk about until the trial has been closed.
Log in or register to get the full forum benefits!
Similar threads
